Meet our biotech speakers

Marcello Agosti, Global Business Development Officer, Takeda

Marcello Agosti

Global Business Development Officer
Takeda
Renée Aguiar-Lucander, CEO, Calliditas

Renée Aguiar-Lucander

CEO
Calliditas
Ingrid Akay, Managing Partner, Hadean Ventures

Ingrid Akay

Managing Partner
Hadean Ventures
Michael Altorfer, CEO, SwissBiotech

Michael Altorfer

CEO
SwissBiotech
Derk Arts, CEO, Castor

Derk Arts

CEO
Castor
Caroline Barelle, CEO, Elasmogen

Caroline Barelle

CEO
Elasmogen
Pierre Belichard, CEO, Enterome Bioscience

Pierre Belichard

CEO
Enterome Bioscience
Gregory Benning, MD & Group Head M&A, Back Bay Life Science Advisors

Gregory Benning

MD & Group Head M&A
Back Bay Life Science Advisors
Maina Bhaman, Partner, Sofinnova

Maina Bhaman

Partner
Sofinnova
Kate Bingham, Managing Partner, SV Health Investors

Kate Bingham

Managing Partner
SV Health Investors
Peter Bisgaard, MD, Nan Fung Life Sciences

Peter Bisgaard

Managing Director
Nan Fung Life Sciences
Elena Bonfiglioli, Managing Director Health Industry EMEA, Microsoft

Elena Bonfiglioli

MD Health Industry EMEA
Microsoft
Eduardo Bravo, CEO, Nordic Nanovector

Eduardo Bravo

CEO
Nordic Nanovector
Søren Bregenholt, CEO, Macrophage

Søren Bregenholt

CEO
Macrophage
Roel Bulthuis, Managing Director, Inkef Capital

Roel Bulthuis

Managing Director
Inkef Capital
Clara Campàs, Partner, Asabys Partners

Clara Campàs

Partner
Asabys Partners
Sergio Capancioni, Director Search & Evaluation Western Europe, AbbVie

Sergio Capancioni

Director Search & Evaluation Western Europe
AbbVie
Giulio Cerroni, CEO, IXICO

Giulio Cerroni

CEO
IXICO
Katherine Cohen, Venture Partner, Panacea Ventures

Katherine Cohen

Venture Partner
Panacea Ventures
Stuart Collinson, CEO, Oxstem

Stuart Collinson

CEO
Oxstem
Grace E. Colón, Ph.D. President & Chief Executive Officer, Incarda Therapeutics

Grace E. Colón

President & Chief Executive Officer
Incarda Therapeutics
Clive Cookson, Science Editor, FT

Clive Cookson

Science Editor
Financial Times
Mick Cooper, Analyst, Trinity Delta

Mick Cooper

Analyst
Trinity Delta
Adelaide Cracco, Head of Life Sciences, European Investment Fund

Adelaide Cracco

Head of Life Sciences
European Investment Fund
Jane Dancer, CBO, F-Star

Jane Dancer

CBO
F-Star
Adrian Dawkes, CEO, PharmaVentures

Adrian Dawkes

CEO
PharmaVentures
John Dawson, CEO, Oxford BioMedica

John Dawson

CEO
Oxford BioMedica
Don deBethizy, Chair of Board, Saniona AB

Don deBethizy

Chair of Board
Saniona AB
Fiona de Hemptinne, Venture Partner, UCB Ventures

Fiona de Hemptinne

Venture Partner
UCB Ventures
Luc Dochez, Managing Director, PrimixBioVentures

Luc Dochez

Managing Director
PrimixBioVentures
Christophe Douat, CEO, MedinCell

Christophe Douat

CEO
MedinCell
Joe Dupere, CEO, Rexgenero

Joe Dupere

CEO
Rexgenero
Lucie Ellis, Managing Editor, In Vivo

Lucie Ellis

Managing Editor
In Vivo
Carl Engleman, VP, Cello Health Consulting

Carl Engleman

Vice President
Cello Health Consulting
Johnston Erwin, VP Corporate Business Development, Eli Lilly

Johnston Erwin

VP Corporate Business Development
Eli Lilly
Mathias Flume, Head of Department, KVWL

Mathias Flume

Head of Department
KVWL
Miriam Frieden, VP Search & Evaluation, Novo Nordisk

Miriam Frieden

VP Search & Evaluation
Novo Nordisk
Jonathan Gertler, Managing Partner & CEO, Back Bay Life Science Advisors

Jonathan Gertler

Managing Partner & CEO
Back Bay Life Science Advisors
Matthew Gline, CFO, Roivant Sciences

Matthew Gline

CFO
Roivant Sciences
Hakan Goker, Senior Investment Director, M Ventures

Hakan Goker

Senior Investment Director
M Ventures
Tim Guilliams, CEO, Healx

Tim Guilliams

CEO
Healx
Mattias Haeggblom, Portfolio Manager, Swedbank Robur

Mattias Haeggblom

Portfolio Manager
Swedbank Robur
Deborah Harland, Partner, SR One

Deborah Harland

Partner
SR One
Theodora Harold, Crescendo

Theo Harold

CEO
Crescendo Biologics
Zishan Haroon, Chairman & General Partner, Julz Co LLC

Zishan Haroon

Chairman & General Partner
Julz Co LLC
Olav Hellebo, CEO, ReNeuron Group

Olav Hellebo

CEO
ReNeuron Group
Jens Hennecke, CBO, Sotio AS

Jens Hennecke

CBO
Sotio AS
William Hicks, Co-chair of Securities & Capital Markets Practice Group, Mintz

William Hicks

Co-chair of Securities & Capital Markets Practice Group
Mintz
John Hodgson

John Hodgson

Independent Consultant
David Horn Solomon, CEO, Silence Therapeutics

David Horn Solomon

CEO
Silence Therapeutics
Leon Hooftman, CMO, ISA Pharmaceuticals

Leon Hooftman

CMO
ISA Pharmaceuticals
Ben Howlett, Director, World Healthcare Journal

Ben Howlett

Director
World Healthcare Journal
Alice Hu Wagner, Managing Director, British Business Bank

Alice Hu Wagner

Managing Director
British Business Bank
Sofia Ioannidou, Partner, Andera Partners

Sofia Ioannidou

Partner
Andera Partners
Annalisa Jenkins, Chair to European biotechs

Annalisa Jenkins

Chair to European biotechs
Adam Kostyal, SVP, Nasdaq

Adam Kostyal

SVP
Nasdaq
Phil L’Hullier, Head of BD, Europe, European Innovation Hub, MSD

Phil L’Hullier

Head of BD, Europe, European Innovation Hub
MSD
Werner Lanthaler, CEO, Evotec

Werner Lanthaler

CEO
Evotec
Kevin Lee, CEO, Bicycle Therapeutics

Kevin Lee

CEO
Bicycle Therapeutics
Søren Lemonius, Managing Partner, Sunstone Capital

Søren Lemonius

Managing General Partner
Sunstone Life Science Ventures
Karen Liu, Partner, 3E BioVentures

Karen Liu

Partner
3E BioVentures
Thomas Lönngren, Former Head of EMA & Advisor, NDA

Thomas Lönngren

Former Head of EMA & Advisor
NDA
Philippe Lopes-Fernandes. SVP, Global Head of BD, Merck

Philippe Lopes-Fernandes

SVP, Global Head of BD & Alliance Management
Merck KGaA
Tim Luker, Senior Director External Innovation, Eli Lilly

Tim Luker

Senior Director External Innovation
Eli Lilly
Ivana Magovčević-Liebisch, CBO, Ipsen

Ivana Magovčević-Liebisch

CBO
Ipsen
Anoop Maini, CEO, Excite Ventures

Anoop Maini

CEO
Excite Ventures
Sean Marett, CBO, CCO, BioNTech AG

Sean Marett

CBO, CCO
BioNTech AG
Giovanni Mariggi, Partner, Medicxi

Giovanni Mariggi

Partner
Medicxi
Giuseppe Mazza, CEO, Engitix

Giuseppe Mazza

CEO
Engitix
Soren Moller, Managing Partner, Novo Seeds

Søren Møller

Managing Partner
Novo Seeds
Edwin Moses, former CEO Ablynx and Chairman to European biotechs

Edwin Moses

former CEO Ablynx and Chairman to European biotechs
Bibhash Mukhopadhyay, Principal, New Enterprise Associates

Bibhash Mukhopadhyay

Principal
New Enterprise Associates
Sumit Nagpal, Global GM, Health Innovation, Comcast NBCUniversal

Sumit Nagpal

CEO & Founder
CareFully
Jordi Naval, CEO, Biocat

Jordi Naval

CEO
Biocat
Jack Nielsen, MD, Vivo Capital

Jack Nielsen

MD
Vivo Capital
Mark O'Herlihy, MD EMEA, IBM Watson Health

Mark O'Herlihy

MD EMEA
IBM Watson Health
Geraldine O’Keeffe, Partner Public Equities, LSP

Geraldine O’Keeffe

Partner Public Equities
LSP
Anthony Pagano, SVP Finance & Corporate Development, Genmab

Anthony Pagano

SVP Finance & Corporate Development
Genmab
Francis Pang, VP Global Market Access, Orchard Therapeutics

Francis Pang

VP Global Market Access
Orchard Therapeutics
Catherine Pickering, CEO, iOnctura

Catherine Pickering

CEO
iOnctura
Cody Powers, Associate Principal, ZS

Cody Powers

Associate Principal
ZS
Ena Prosser, Partner, FH Partners

Ena Prosser

Partner
FH Partners
Kieran Rooney, VP Strategic Alliances and Licensing, Amryt Pharma

Kieran Rooney

VP Strategic Alliances and Licensing
Amryt Pharma
Thibaut Roulon, Investment Director - Life Sciences, Bpifrance

Thibaut Roulon

Investment Director - Life Sciences
Bpifrance
Ed Saltzman, Executive Chairman, Cello Health BioConsulting

Ed Saltzman

Executive Chairman
Cello Health BioConsulting
Mirko Scherer, CEO, CoFeS China Ltd

Mirko Scherer

CEO
CoFeS China Ltd
Denise Scots-Knight, CEO, Mereo Biopharma

Denise Scots-Knight

CEO
Mereo Biopharma
Sara Secall, Investment Director & Partner, Inveready Asset Management

Sara Secall

Investment Director & Partner
Inveready Asset Management
Graziano Seghezzi, Managing Partner, Sofinnova Partners

Graziano Seghezzi

Managing Partner
Sofinnova Partners
Melanie Senior, Analyst and Specialist Writer, Life Sciences

Melanie Senior

Analyst and Specialist Writer
Life Sciences
Sarah Shackleton, Partner, Marketing & Talent, Abingworth

Sarah Shackleton

Partner, Marketing & Talent
Abingworth
Nigel Sheail, Global Head of M&A and BD&L, Novartis

Nigel Sheail

Global Head of M&A and BD&L
Novartis
Ari Silverman, Partner, Mavie Technologies

Ari Silverman

Partner
Mavie Technologies
Kyparissia Sirinakis, Managing Partner, Epidarex

Kyparissia Sirinakis

Managing Partner
Epidarex
Ulrica Slåne Bjerke, CIO, Arctic Aurora LifeScience

Ulrica Slåne Bjerke

CIO
Arctic Aurora LifeScience
Yochi Slonim, Co-Founder & CEO, Anima Biotech Inc

Yochi Slonim

Co-Founder & CEO
Anima Biotech Inc
Sander Slootweg, Managing Partner, Forbion

Sander Slootweg

Managing Partner
Forbion
Andy Smith, Analyst, Equity Development

Andy Smith

Analyst
Equity Development
Jens Stegemann, Former CEO, Breath Therapeutics

Jens Stegemann

Former CEO
Breath Therapeutics
Carl Sterritt, CEO, Shield Therapeutics

Carl Sterritt

CEO
Shield Therapeutics
John Strafford, VP Head of BD, Silence Therapeutics

John Strafford

VP Head of BD,
Silence Therapeutics
Ben Thorpe, Goldman Sachs

Ben Thorpe

Head of Healthcare Banking, EMEA
Goldman Sachs
Rafaèle Tordjman, Founder & CEO, Jeito

Rafaèle Tordjman

Founder & CEO
Jeito
Marina Udier

Marina Udier

CEO
NousCom
Lisa Urquhart, Editor, Vantage

Lisa Urquhart

Editor
Vantage
Onno Van de Stolpe, CEO, Galapagos

Onno Van de Stolpe

CEO
Galapagos
Lars van der Veen, COO, iOnctura

Lars van der Veen

COO
iOnctura
Erik van den Berg, CEO, AM-Pharma

Erik van den Berg

CEO
AM-Pharma
Montserrat Vendrell, General Partner, Alta Life Sciences

Montserrat Vendrell

General Partner
Alta Life Sciences
Annemiek Verkamman, Managing Director, HollandBIO

Annemiek Verkamman

Managing Director
HollandBIO
Cedric Ververken, CEO, Confo Therapeutics

Cedric Ververken

CEO
Confo Therapeutics
Guillaume Vignon, SVP Business Development, BeiGene

Guillaume Vignon

SVP Business Development
BeiGene
Jason Ward, Group Director, AstraZeneca

Jason Ward

Group Director
AstraZeneca
Marietta Wu, Managing Director, Quan Capital

Marietta Wu

Managing Director
Quan Capital
Donald Xu, Managing Partner, Lynx Financial

Donald Xu

Managing Partner
Lynx Financial
Dan Zhang, Executive Chairman, Fountain Medical Development

Dan Zhang

Executive Chairman
Fountain Medical Development
Constantinos Ziogas, Head of SME Office, European Medicines Agency

Constantinos Ziogas

Head of SME Office
European Medicines Agency

DOWNLOAD FULL AGENDA